Abhaya M Dandekar et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(10), 3721-3725 (2012-02-23)
We postulated that a synergistic combination of two innate immune functions, pathogen surface recognition and lysis, in a protein chimera would lead to a robust class of engineered antimicrobial therapeutics for protection against pathogens. In support of our hypothesis, we